Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Recurrent or Metastatic Head and Neck Cancer
NCT01620242Phase 2Completed
- Sponsor
- Unicancer
- Start
- Apr 2012
- Primary completion
- Jun 2013
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in head and neck cancer (HNC), sponsored by Unicancer. Started Apr 2012; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT01620242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620242.